Semaglutide 2.4 Mg for the Management of Overweight and Obesity: Systematic Literature Review and Meta-Analysis

PURPOSE: Semaglutide has demonstrated safe and effective weight loss for overweight and obesity, including participants with concomitant type 2 diabetes mellitus (T2DM), in randomized placebo-controlled trials (RCTs). We conducted a systematic literature review (SLR) and network meta-analyses (NMA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Inger, Hardy, Emily, Mitchell, Stephen, Batson, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769143/
https://www.ncbi.nlm.nih.gov/pubmed/36569429
http://dx.doi.org/10.2147/DMSO.S392952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769143/
https://www.ncbi.nlm.nih.gov/pubmed/36569429
http://dx.doi.org/10.2147/DMSO.S392952

Ejemplares similares